IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management III, LLC

Q1 2020 Holdings

Filed 2020-05-14 | 9 holdings | $62.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Myokardia, Inc.COM62857M105$18.1K385,45228.8%
Epizyme, Inc.(EPZMEUR)COM29428V104$11.1K713,81217.6%
Blueprint Medicines Corporation(2L9)COM09627Y109$9.9K169,90015.8%
Natera, Inc.(NTRA)COM632307104$6.2K208,7689.9%
Immunomedics, Inc.(IMMU)COM452907108$5.4K400,0008.6%
Aerie Pharmaceuticals, Inc.(AERIEUR)COM00771V108$4.8K356,4927.7%
Acceleron Pharma Inc.(XLRN)COM00434H108$3.8K42,0306.0%
Biohaven Pharmaceutical Holding Company Ltd.(BHVN)COMG11196105$2.1K62,2453.4%
FibroGen, Inc.(FGENEUR)COM31572Q808$1.4K40,0002.2%